Pricing Log in Create free account

CDT Equity Inc. (CDT) vs Seelos Therapeutics, Inc. (SEELQ)

CDT Equity Inc. and Seelos Therapeutics, Inc. are both Biotechnology companies. Seelos Therapeutics, Inc. is the larger, with a market value of $700.0K against $240.0K — 2.9× the size. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs −21.3%). Across the 11 metrics below, Seelos Therapeutics, Inc. leads on 6 and CDT Equity Inc. on 5.

Valuation

Metric CDT SEELQ Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.50 9.21
Earnings yield 372,911,481.96% 0.00% (33.15%)
Free cash flow yield (232,570.42%) 0.00% (25.50%)

Profitability

Metric CDT SEELQ Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (1,480.04%) 0.00%
Net margin 0.00% 203.13% 0.00%
Free cash flow margin 0.00% (659.09%) 0.00%
Return on equity (69.68%) (10.86%) (56.36%)
Return on assets (55.16%) 57.34% (48.04%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT SEELQ Biotechnology median
Revenue growth (TTM) — (51.45%) 6.02%
EPS growth (last fiscal year) 52.16% 62.72% 30.26%
Revenue growth, 5-year CAGR — (22.63%) 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT SEELQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.13 0.08 4.72
Net debt to EBITDA 0.05 0.09 0.96

Dividend

Metric CDT SEELQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CDT SEELQ Biotechnology median
Market cap 240.00k 700.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack